NEW YORK (Reuters Health) – Women with heavy menstrual bleeding may find that the levonorgestrel-releasing intrauterine system (Mirena; Bayer Schering) is more effective than oral medroxyprogesterone acetate in…
NEW YORK (Reuters Health) – The intensity of bortezomib-based regimens used to treat multiple myeloma in elderly patents can be reduced in order to lessen toxicity, without jeopardizing…
NEW YORK (Reuters Health) – After surgically induced remission of Crohn’s disease, treatment with mesalamine reduces the risk of relapse somewhat; sulfasalazine, however, has no apparent benefit, according…
NEW YORK (Reuters Health) – Among adult patients being treated for hematologic malignancies and who are at high risk for tumor lysis syndrome with hyperuricemia, intravenous rasburicase does…
NEW YORK (Reuters Health) – The use of angiotensin blocking therapy before cardiac surgery is not associated with postoperative atrial fibrillation (AF), researchers report in the August American…
NEW YORK (Reuters Health) – In high-risk patients having percutaneous coronary intervention for ST-segment elevation acute myocardial infarction (STEMI), bivalirudin was more effective than unfractionated heparin plus a…
NEW YORK (Reuters Health) – Major surgery often leads to transient thyroid hormone derangements. When it does, short-duration T3 therapy has no apparent benefit, according to a new…
NEW YORK (Reuters Health) – Perioperative dexamethasone does not boost the risk of post-tonsillectomy hemorrhage, according to a large retrospective study reported in the August Archives of Otolaryngology…
NEW YORK (Reuters Health) – Children with mild to moderate asthma have better pulmonary function and require less rescue medication if they take budesonide/formoterol (BUD/FM; Symbicort) twice a…
NEW YORK (Reuters Health) – Outcomes in patients with coexistent glaucoma and cataracts who undergo simultaneous trabeculectomy and lens extraction are no different whether the two procedures are…
